BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24098949)

  • 1. Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment.
    Jiménez-Arellanes A; Luna-Herrera J; Cornejo-Garrido J; López-García S; Castro-Mussot ME; Meckes-Fischer M; Mata-Espinosa D; Marquina B; Torres J; Hernández-Pando R
    BMC Complement Altern Med; 2013 Oct; 13():258. PubMed ID: 24098949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity against multidrug-resistant Mycobacterium tuberculosis in Mexican plants used to treat respiratory diseases.
    Jimenez-Arellanes A; Meckes M; Ramirez R; Torres J; Luna-Herrera J
    Phytother Res; 2003 Sep; 17(8):903-8. PubMed ID: 13680821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aegicerin, the first oleanane triterpene with wide-ranging antimycobacterial activity, isolated from Clavija procera.
    Rojas R; Caviedes L; Aponte JC; Vaisberg AJ; Lewis WH; Lamas G; Sarasara C; Gilman RH; Hammond GB
    J Nat Prod; 2006 May; 69(5):845-6. PubMed ID: 16724857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimycobacterial, docking and molecular dynamic studies of pentacyclic triterpenes from Buddleja saligna leaves.
    Singh A; Venugopala KN; Khedr MA; Pillay M; Nwaeze KU; Coovadia Y; Shode F; Odhav B
    J Biomol Struct Dyn; 2017 Sep; 35(12):2654-2664. PubMed ID: 28278765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimycobacterial triterpenoids from Lantana hispida (Verbenaceae).
    Jiménez-Arellanes A; Meckes M; Torres J; Luna-Herrera J
    J Ethnopharmacol; 2007 May; 111(2):202-5. PubMed ID: 17236730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis.
    Ge F; Zeng F; Liu S; Guo N; Ye H; Song Y; Fan J; Wu X; Wang X; Deng X; Jin Q; Yu L
    J Med Microbiol; 2010 May; 59(Pt 5):567-572. PubMed ID: 20075118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimycobacterial activity of methanolic plant extract of Artemisia capillaris containing ursolic acid and hydroquinone against Mycobacterium tuberculosis.
    Jyoti MA; Nam KW; Jang WS; Kim YH; Kim SK; Lee BE; Song HY
    J Infect Chemother; 2016 Apr; 22(4):200-8. PubMed ID: 26867795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage Activation by Ursolic and Oleanolic Acids during Mycobacterial Infection.
    López-García S; Castañeda-Sanchez JI; Jiménez-Arellanes A; Domínguez-López L; Castro-Mussot ME; Hernández-Sanchéz J; Luna-Herrera J
    Molecules; 2015 Aug; 20(8):14348-64. PubMed ID: 26287131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
    Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimutagenicity of ursolic acid and oleanolic acid against doxorubicin-induced clastogenesis in Balb/c mice.
    Aparecida Resende F; de Andrade Barcala CA; da Silva Faria MC; Kato FH; Cunha WR; Tavares DC
    Life Sci; 2006 Aug; 79(13):1268-73. PubMed ID: 16647723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.
    Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D
    J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models.
    Rivas-Santiago B; Castañeda-Delgado JE; Rivas Santiago CE; Waldbrook M; González-Curiel I; León-Contreras JC; Enciso-Moreno JA; del Villar V; Mendez-Ramos J; Hancock RE; Hernandez-Pando R
    PLoS One; 2013; 8(3):e59119. PubMed ID: 23555622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis.
    Rivas-Santiago B; Rivas Santiago CE; Castañeda-Delgado JE; León-Contreras JC; Hancock RE; Hernandez-Pando R
    Int J Antimicrob Agents; 2013 Feb; 41(2):143-8. PubMed ID: 23141114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of liposomes containing 4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine in a murine model of progressive pulmonary tuberculosis.
    Mata-Espinosa D; Molina-Salinas GM; Barrios-Payán J; Navarrete-Vázquez G; Marquina B; Ramos-Espinosa O; Bini EI; Baeza I; Hernández-Pando R
    Pulm Pharmacol Ther; 2015 Jun; 32():7-14. PubMed ID: 25843004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antimycobacterial activity of crude extracts and solvent fractions of selected Ethiopian medicinal plants.
    Kahaliw W; Aseffa A; Abebe M; Teferi M; Engidawork E
    BMC Complement Altern Med; 2017 Mar; 17(1):143. PubMed ID: 28274226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacious In Vitro and In Vivo Effects of Dihydrosphingosine-Ethambutol Analogues Against Susceptible and Multi-drug-resistant Mycobacterium tuberculosis.
    Olmo ED; Molina-Salinas GM; Bini EI; González-Hernández S; Bustos LA; Escarcena R; Marquina-Castillo B; Mata-Espinosa D; Barrios-Payán J; González-Ramírez D; Fernández SS; San Feliciano A; Hernández-Pando R
    Arch Med Res; 2016 May; 47(4):262-70. PubMed ID: 27664485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimycobacterial activity of cinnamate-based esters of the triterpenes betulinic, oleanolic and ursolic acids.
    Tanachatchairatana T; Bremner JB; Chokchaisiri R; Suksamrarn A
    Chem Pharm Bull (Tokyo); 2008 Feb; 56(2):194-8. PubMed ID: 18239308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A significant therapeutic effect of immunoglobulins administered alone, or in combination with conventional chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains.
    Olivares N; Rodriguez Y; Zatarain-Barron ZL; Marquina B; Mata-Espinosa D; Barrios-Payán J; Parada C; Moguel B; Espitia-Pinzón C; Estrada I; Hernandez-Pando R
    Pathog Dis; 2017 Dec; 75(9):. PubMed ID: 29186408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of traditional Chinese medicine Niubeixiaohe in mouse tuberculosis models.
    Liang Y; Wang X; Song J; Wang L; Chen D; Yang Y; Bai X; Wang J; Shi Y; Chen S; Liu J; Yang C; Luo H; Liu G; Wu X
    J Ethnopharmacol; 2017 Jan; 195():318-323. PubMed ID: 27884716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel benzothiazinethione analogue SKLB-TB1001 displays potent antimycobacterial activities in a series of murine models.
    Gao C; Ye TH; Peng CT; Shi YJ; You XY; Xiong L; Ran K; Zhang LD; Zeng XX; Wang NY; Yu LT; Wei YQ
    Biomed Pharmacother; 2017 Apr; 88():603-609. PubMed ID: 28142116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.